These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 7168451)

  • 41. Federal court vindicates IPA fee setting and membership decisions.
    Barnes CE
    Internist; 1989 Jan; 30(1):31. PubMed ID: 10312856
    [No Abstract]   [Full Text] [Related]  

  • 42. Arizona v. Maricopa County: a stern antitrust warning to healthcare providers.
    Halper HR
    Healthc Financ Manage; 1982 Oct; 36(10):38-42. PubMed ID: 10315212
    [No Abstract]   [Full Text] [Related]  

  • 43. PPOs facing potential antitrust worries.
    Tarnoff S
    Bus Insur; 1985 Jul; 19(29):16, 20. PubMed ID: 10271746
    [No Abstract]   [Full Text] [Related]  

  • 44. An assessment of the anticompetitive effects of preferred provider organizations.
    Greaney TL; Sindelar JL
    Inquiry; 1987; 24(4):384-91. PubMed ID: 2961699
    [TBL] [Abstract][Full Text] [Related]  

  • 45. More private, less government PPA antitrust action.
    Burda D
    Hospitals; 1987 Feb; 61(3):52. PubMed ID: 3804258
    [No Abstract]   [Full Text] [Related]  

  • 46. Preferred provider organizations, price-fixing and Section 1 of the Sherman Act.
    Bluhm RJ
    Health Matrix; 1987; 5(3):9-16. PubMed ID: 10285386
    [TBL] [Abstract][Full Text] [Related]  

  • 47. The legal framework for effective competition.
    Berenson RA; Hastings DA; Kopit WG
    Baxter Health Policy Rev; 1996; 2():235-65. PubMed ID: 11066262
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Vertical restraints and powerful health insurers: exclusionary conduct masquerading as managed care?
    Miller FH
    Law Contemp Probl; 1988; 51(2):195-236. PubMed ID: 10295963
    [No Abstract]   [Full Text] [Related]  

  • 49. The preferred provider organization -- pro-competitive alternative or antitrust problem?
    Enders RJ
    Hosp Forum; 1982; 25(6):42-4. PubMed ID: 10257108
    [No Abstract]   [Full Text] [Related]  

  • 50. Alternative delivery systems are focus of antitrust scrutiny.
    Scammon DL; Fuller DA; Sheffet MJ
    J Health Care Mark; 1987 Jun; 7(2):77-81. PubMed ID: 10282715
    [No Abstract]   [Full Text] [Related]  

  • 51. Peer review of fees by physician groups: antitrust issues.
    Scott M
    Health Law Vigil; 1986 Jul; 9(14):5-8. PubMed ID: 10277308
    [No Abstract]   [Full Text] [Related]  

  • 52. Antitrust implications of health planning: National Gerimedical Hospital and Gerontology Center v. Blue Cross of Kansas City.
    Chase JB
    Am J Law Med; 1982; 8(3):321-48. PubMed ID: 7168454
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Antitrust implications of allied health practitioner privilege decisions and hospital-physician exclusive contracts.
    Miles JJ
    Med Staff Couns; 1988; 2(1):19-26. PubMed ID: 10289814
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Court dismisses antitrust violation claim.
    Chandler JA
    Health Law Vigil; 1985 Aug; 8(17):6. PubMed ID: 10324433
    [No Abstract]   [Full Text] [Related]  

  • 55. Private cost containment.
    Havighurst CC; Hackbarth GM
    N Engl J Med; 1979 Jun; 300(23):1298-305. PubMed ID: 440332
    [TBL] [Abstract][Full Text] [Related]  

  • 56. The antitrust swamp: how can healthcare professionals avoid it?
    Weller CD
    Healthc Financ Manage; 1982 Oct; 36(10):26-8, 30-6. PubMed ID: 10315211
    [No Abstract]   [Full Text] [Related]  

  • 57. Court decisions give Blues plans one win, one loss in separate antitrust cases.
    Halper HR; Kazon PM
    Bus Health; 1987 Mar; 4(5):51-2. PubMed ID: 10280673
    [No Abstract]   [Full Text] [Related]  

  • 58. Medical care collection or recovery. Department of Veterans Affairs. Final rule.
    Fed Regist; 1999 Apr; 64(80):22675-83. PubMed ID: 10558484
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Antitrust implications of medical technology assessment.
    Rose M; Leibenluft RF
    N Engl J Med; 1986 Jun; 314(23):1490-3. PubMed ID: 3702964
    [No Abstract]   [Full Text] [Related]  

  • 60. How antitrust laws are changing the health care industry.
    Rosenfield RH; Harwell JD
    Health Care Strateg Manage; 1985 Jul; 3(7):4-10. PubMed ID: 10271815
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.